Encrypted login | home

Program Information

Optimization for Contrast-Enhanced Spectral Mammography Based On Photon-Counting Detectors

no image available
H Ding

H Ding*, S Molloi , University of California, Irvine, CA

Presentations

WE-DE-207B-1 (Wednesday, August 3, 2016) 10:15 AM - 12:15 PM Room: 207B


Purpose: To investigate the feasibility of optimizing the imaging parameters for contrast-enhanced spectral mammography based on Si strip photon-counting detectors.

Methods: A computer simulation model using polyenergetic spectra from a tungsten anode x-ray tube and a Si-based photon-counting detector was evaluated for contrast-enhanced spectral mammography. The simulation traces the emission of photons from the x-ray source, attenuation through the breast and subsequent absorption in the detector. The breast was modeled as a mixture of adipose and mammary gland tissues with a breast density of 30%. A 4 mm iodine signal with a concentration of 4 mg/ml was used to simulate the enhancement of a lesion. Quantum efficiency of the detector was calculated based on the effective attenuation length in the Si strips. The figure-of-merit (FOM), which was defined as the decomposed iodine signal-to-noise ratio (SNR) with respect to the square root of the mean glandular dose (MGD), was chosen to optimize the imaging parameters, in terms of beam energy, splitting energy, and pre-filtrations for breast of various thicknesses and densities.

Results: The optimal imaging parameters, which lead to the highest FOM, were found at a beam energy of 45 kVp with a splitting energy at 34 keV for an averaged breast thickness of 4 cm with a standard 0.75 mm Al pre-filtration. The optimal tube voltage varied slightly from 46 to 44 kVp as the breast thickness increases from 2 to 8 cm. The optimal tube voltage decreased to 42 kVp when the Al pre-filtration was increased to 3 mm.

Conclusion: This simulation study predicted the optimal imaging parameters for application of photon-counting spectral mammography to contrast-enhanced imaging. The simulation results laid the ground work for future phantom and clinical studies.

Funding Support, Disclosures, and Conflict of Interest: Grant funding from Philips Medical Systems.


Contact Email: